Bortezomib EVER Pharma 2,5 mg/ml otopina za injekciju
| Name | Bortezomib EVER Pharma 2,5 mg/ml otopina za injekciju |
|---|---|
| Marketing Authorisation Number | HR-H-234275465 |
| Active Substance | bortezomib |
| Composition | 1 ml otopine za injekciju sadrži 2,5 mg bortezomiba (u obliku estera boronatne kiseline i manitola) jedna bočica s 1 ml otopine za injekciju sadrži 2,5 mg bortezomiba (u obliku estera boronatne kiseline i manitola) jedna bočica s 1,4 ml otopine za injekciju sadrži 3,5 mg bortezomiba (u obliku estera boronatne kiseline i manitola) |
| Pharmaceutical Form | otopina za injekciju |
| Manufacturer | Ever Pharma Jena GmbH, Jena, Njemačka Ever Pharma Jena GmbH, Jena, Njemačka |
| Marketing Authorisation Holder | EVER Valinject GmbH, Oberburgau 3, Unterach am Attersee, Austrija |
| Marketing Authorisation Date | 13.10.2022 |
| MA Period of Validity | 13.10.2027 |
| Classification Number | UP/I-530-09/22-01/97 |
| Registration Number | 381-12-01/70-22-07 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L01XG01 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
